Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hopkins

Showing results (881-890 of 884) with videos related to

Pageof 89
Sort By:
You have reached the last page of results.This site can display upto 884 results.
Scientific Reports|August 24, 2018
A platform for discovery of functional cell-penetrating peptides for efficient multi-cargo intracellular deliveryKatrin Hoffmann, Nadia Milech, Suzy M Juraja, et al.
Health and Quality of Life Outcomes|November 29, 2025
Using machine learning to predict patient-reported symptom clusters in prostate cancer patients receiving radiotherapyElke Rammant, Emile Deman, Valérie Fonteyne, et al.
Cancers|June 28, 2023
Prediction of Prostate Cancer Biochemical and Clinical Recurrence Is Improved by IHC-Assisted Grading Using Appl1, Sortilin and Syndecan-1Jessica M Logan, Ashley M Hopkins, Carmela Martini, et al.
Pathology|September 11, 2022
Aberrant protein expression of Appl1, Sortilin and Syndecan-1 during the biological progression of prostate cancerCarmela Martini, Jessica M Logan, Alexandra Sorvina, et al.
Pageof 89

Showing results (881-890 of 884) with videos related to

Sort By:
Pageof 89
You have reached the last page of results.This site can display upto 884 results.
Scientific Reports|August 24, 2018
A platform for discovery of functional cell-penetrating peptides for efficient multi-cargo intracellular deliveryKatrin Hoffmann, Nadia Milech, Suzy M Juraja, et al.
Health and Quality of Life Outcomes|November 29, 2025
Using machine learning to predict patient-reported symptom clusters in prostate cancer patients receiving radiotherapyElke Rammant, Emile Deman, Valérie Fonteyne, et al.
Cancers|June 28, 2023
Prediction of Prostate Cancer Biochemical and Clinical Recurrence Is Improved by IHC-Assisted Grading Using Appl1, Sortilin and Syndecan-1Jessica M Logan, Ashley M Hopkins, Carmela Martini, et al.
Pathology|September 11, 2022
Aberrant protein expression of Appl1, Sortilin and Syndecan-1 during the biological progression of prostate cancerCarmela Martini, Jessica M Logan, Alexandra Sorvina, et al.
Pageof 89